Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report

被引：0
|
作者：
R. Trappe
A. Loew
P. Thuss-Patience
B. Dörken
H. Riess
机构：
[1] Charité Universitätsmedizin Berlin,Department of Hematology and Oncology
来源：
Annals of Hematology | 2006年 / 85卷
关键词：
Idiopathic Thrombocytopenic Purpura; Lupus Anticoagulant; High Platelet Count; Chronic Idiopathic Thrombocytopenic Purpura; Recurrent Fetal Loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：134 / 135
页数：1
相关论文
共 50 条
  • [41] Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 antibody Rituximab.
    Giagounidis, AAN
    Anhuf, J
    Schneider, P
    Germing, U
    Soehngen, D
    Quabeck, K
    Aul, C
    BLOOD, 2001, 98 (11) : 523A - 523A
  • [42] Idiopathic membranous nephropathy (IMN) treatment with anti-CD20 monoclonal antibody Rituximab
    Lionaki, Sofia
    Sfikakis, Petros
    Theodoropoulou, Eleni
    Skalioti, Chrisanthi
    Iniotaki, Aliki
    Nakopoulou, Lydia
    Boletis, Ioannis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 334 - 335
  • [43] Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)
    Fernando Pinto, Luis
    Candia, Liliana
    Garcia, Patricia
    Ignacio Marin, Juan
    Pachon, Ines
    Espinoza, Luis R.
    Marquez, Javier
    RESPIRATION, 2009, 78 (01) : 106 - 109
  • [44] Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    Hagberg, H
    Lundholm, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 609 - 611
  • [45] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [46] Rituximab: An anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura
    Aggarwal, A
    Catlett, JP
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1209 - 1212
  • [47] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Smith, MR
    ONCOGENE, 2003, 22 (47) : 7359 - 7368
  • [48] Current clinical trials of the anti-CD20 monoclonal antibody rituximab
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 1437 - +
  • [49] Rituximab (anti-CD20) for the treatment of primary Sjogren's syndrome.
    Pijpe, J
    Bootsma, H
    Van Imhoff, G
    Vissink, A
    Mansour, K
    Van der Wal, J
    Roozendaal, C
    Kluin, P
    Spijkervet, F
    Roodenburg, J
    Kallenberg, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S575 - S575
  • [50] EFFECT OF ANTI-CD20 MONOCLONAL ANTIBODY (RITUXIMAB) IN IMMUNE THROMBOCYTOPENIA. EXPERIENCE IN A PERUVIAN HOSPITAL
    Untama, J. L.
    Del Carpio, D.
    Navarro, J.
    HAEMATOLOGICA, 2012, 97 : 687 - 687
12345